AU Patent

AU2008206599A1 — Pharmaceutically acceptable salts of 11- (4-aminophenyl) -19-n0rpregna-4,9 (10) -diene-3, 20-dione derivatives

Assigned to Repros Therapeutics Inc · Expires 2008-07-24 · 18y expired

What this patent protects

Patent listed against ulipristal-acetate.

Drugs covered by this patent

Patent Metadata

Patent number
AU2008206599A1
Jurisdiction
AU
Classification
—
Expires
2008-07-24
Drug substance claim
No
Drug product claim
No
Assignee
Repros Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.